RENALYTIX AI PLC-ADR (RNLX) Fundamental Analysis & Valuation

NASDAQ:RNLX • US75973T1016

Current stock price

0.2071 USD
+0.01 (+5.66%)
At close:
0.13 USD
-0.08 (-37.23%)
After Hours:

This RNLX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. RNLX Profitability Analysis

1.1 Basic Checks

  • RNLX had negative earnings in the past year.
  • RNLX had a negative operating cash flow in the past year.
  • RNLX had negative earnings in each of the past 5 years.
  • RNLX had a negative operating cash flow in each of the past 5 years.
RNLX Yearly Net Income VS EBIT VS OCF VS FCFRNLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M -50M

1.2 Ratios

  • With a Return On Assets value of -109.75%, RNLX is not doing good in the industry: 89.19% of the companies in the same industry are doing better.
  • RNLX's Return On Equity of -250.48% is on the low side compared to the rest of the industry. RNLX is outperformed by 83.78% of its industry peers.
Industry RankSector Rank
ROA -109.75%
ROE -250.48%
ROIC N/A
ROA(3y)-76.55%
ROA(5y)-54.96%
ROE(3y)-138.17%
ROE(5y)-92.72%
ROIC(3y)N/A
ROIC(5y)N/A
RNLX Yearly ROA, ROE, ROICRNLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 200 -200 400 600 800

1.3 Margins

  • With a Gross Margin value of 20.60%, RNLX is not doing good in the industry: 86.49% of the companies in the same industry are doing better.
  • The Profit Margin and Operating Margin are not available for RNLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RNLX Yearly Profit, Operating, Gross MarginsRNLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. RNLX Health Analysis

2.1 Basic Checks

  • RNLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, RNLX has more shares outstanding
  • Compared to 1 year ago, RNLX has a worse debt to assets ratio.
RNLX Yearly Shares OutstandingRNLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
RNLX Yearly Total Debt VS Total AssetsRNLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -5.75, we must say that RNLX is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of RNLX (-5.75) is worse than 83.78% of its industry peers.
  • RNLX has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
  • RNLX has a Debt to Equity ratio of 0.41. This is in the lower half of the industry: RNLX underperforms 62.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z -5.75
ROIC/WACCN/A
WACC6.65%
RNLX Yearly LT Debt VS Equity VS FCFRNLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 50M

2.3 Liquidity

  • A Current Ratio of 1.76 indicates that RNLX should not have too much problems paying its short term obligations.
  • RNLX has a Current ratio of 1.76. This is comparable to the rest of the industry: RNLX outperforms 48.65% of its industry peers.
  • RNLX has a Quick Ratio of 1.71. This is a normal value and indicates that RNLX is financially healthy and should not expect problems in meeting its short term obligations.
  • RNLX has a Quick ratio (1.71) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.71
RNLX Yearly Current Assets VS Current LiabilitesRNLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. RNLX Growth Analysis

3.1 Past

  • RNLX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.23%, which is quite impressive.
  • RNLX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.58%.
EPS 1Y (TTM)27.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.99%
Revenue 1Y (TTM)14.58%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-68.35%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.35% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 73.89% on average over the next years. This is a very strong growth
EPS Next Y59.3%
EPS Next 2Y32.95%
EPS Next 3Y21.35%
EPS Next 5YN/A
Revenue Next Year39.85%
Revenue Next 2Y68.91%
Revenue Next 3Y73.89%
Revenue Next 5YN/A

3.3 Evolution

RNLX Yearly Revenue VS EstimatesRNLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
RNLX Yearly EPS VS EstimatesRNLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

1

4. RNLX Valuation Analysis

4.1 Price/Earnings Ratio

  • RNLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RNLX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RNLX Price Earnings VS Forward Price EarningsRNLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RNLX Per share dataRNLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • RNLX's earnings are expected to grow with 21.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.95%
EPS Next 3Y21.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RNLX Dividend Analysis

5.1 Amount

  • RNLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

RNLX Fundamentals: All Metrics, Ratios and Statistics

RENALYTIX AI PLC-ADR

NASDAQ:RNLX (10/7/2024, 8:16:27 PM)

After market: 0.13 -0.08 (-37.23%)

0.2071

+0.01 (+5.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-15
Earnings (Next)10-29
Inst Owners4.26%
Inst Owner Change0%
Ins Owners6.06%
Ins Owner Change0%
Market Cap17.18M
Revenue(TTM)3.40M
Net Income(TTM)-46.22M
Analysts84
Price Target2.67 (1189.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)30.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)6.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.05
P/FCF N/A
P/OCF N/A
P/B 0.93
P/tB 2.89
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0.04
BVpS0.22
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -109.75%
ROE -250.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.6%
FCFM N/A
ROA(3y)-76.55%
ROA(5y)-54.96%
ROE(3y)-138.17%
ROE(5y)-92.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.71
Altman-Z -5.75
F-Score2
WACC6.65%
ROIC/WACCN/A
Cap/Depr(3y)34.78%
Cap/Depr(5y)392%
Cap/Sales(3y)44.23%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.99%
EPS Next Y59.3%
EPS Next 2Y32.95%
EPS Next 3Y21.35%
EPS Next 5YN/A
Revenue 1Y (TTM)14.58%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-68.35%
Revenue Next Year39.85%
Revenue Next 2Y68.91%
Revenue Next 3Y73.89%
Revenue Next 5YN/A
EBIT growth 1Y26.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.82%
EBIT Next 3Y19.78%
EBIT Next 5YN/A
FCF growth 1Y29.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.57%
OCF growth 3YN/A
OCF growth 5YN/A

RENALYTIX AI PLC-ADR / RNLX Fundamental Analysis FAQ

What is the fundamental rating for RNLX stock?

ChartMill assigns a fundamental rating of 2 / 10 to RNLX.


What is the valuation status for RNLX stock?

ChartMill assigns a valuation rating of 1 / 10 to RENALYTIX AI PLC-ADR (RNLX). This can be considered as Overvalued.


How profitable is RENALYTIX AI PLC-ADR (RNLX) stock?

RENALYTIX AI PLC-ADR (RNLX) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for RNLX stock?

The Earnings per Share (EPS) of RENALYTIX AI PLC-ADR (RNLX) is expected to grow by 59.3% in the next year.